View Filing Data

Print Document View Excel Document

Document and Entity Information - shares	6 Months Ended
Document and Entity Information - shares	Jun. 30, 2013	Jul. 24, 2013
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2013
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	Q2
Trading Symbol	XRAY
Entity Registrant Name	DENTSPLY INTERNATIONAL INC /DE/
Entity Central Index Key	0000818479
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		142,288,292

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Net sales	$ 761,010	$ 762,994	$ 1,493,094	$ 1,479,407
Cost of products sold	346,054	355,525	689,938	679,188
Gross profit	414,956	407,469	803,156	800,219
Selling, General and Administrative Expense	289,921	296,034	583,598	600,388
Restructuring and other costs	2,169	2,528	2,834	3,765
Operating income	122,866	108,907	216,724	196,066
Other income and expenses:
Interest expense	11,507	14,323	26,728	30,105
Interest income	(2,243)	(1,984)	(4,418)	(3,862)
Other expense (income), net	4,223	982	7,141	1,045
Income before income taxes	109,379	95,586	187,273	168,778
Income Tax Expense (Benefit)	22,870	14,875	26,412	29,590
Equity in net earnings (loss) of unconsolidated affilated company	2,182	1,329	403	(2,919)
Net income	88,691	82,040	161,264	136,269
Less: Net income attributable to noncontrolling interests	1,463	1,276	2,351	2,220
Net income attributable to DENTSPLY International	$ 87,228	$ 80,764	$ 158,913	$ 134,049
Earnings per common share:
Basic (in dollars per share)	$ 0.61	$ 0.57	$ 1.11	$ 0.95
Diluted (in dollars per share)	$ 0.60	$ 0.56	$ 1.10	$ 0.93
Weighted average common shares outstanding:
Basic (in shares)	142,922	141,737	142,849	141,729
Diluted (in shares)	145,133	143,863	145,107	143,908

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax	$ 540	$ 1,726	$ 3,316	$ 1,666
Net income	88,691	82,040	161,264	136,269
Other comprehensive income (loss), net of tax:
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	5,886	(178,746)	(88,256)	(45,275)
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax	(13,362)	47,089	14,756	14,957
Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax	(16,629)	(7,954)	(8,989)	15,046
Other Comprehensive Income (Loss), Net of Tax	(23,565)	(137,885)	(79,173)	(13,606)
Total comprehensive (loss) income	65,126	(55,845)	82,091	122,663
Less: Comprehensive (loss) income attributable to noncontrolling interests	2,019	(928)	2,200	1,356
Comprehensive (loss) income attributable to DENTSPLY International	$ 63,107	$ (54,917)	$ 79,891	$ 121,307

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2013	Dec. 31, 2012
Current Assets:
Cash and cash equivalents	$ 57,027	$ 80,132
Accounts and notes receivable-trade, net	499,006	442,412
Inventories, net	433,189	402,940
Prepaid expenses and other current assets	180,811	185,612
Total Current Assets	1,170,033	1,111,096
Property, plant and equipment, net	605,028	614,705
Identifiable intangible assets, net	786,667	830,642
Goodwill, net	2,158,529	2,210,953
Other noncurrent assets, net	154,426	204,901
Total Assets	4,874,683	4,972,297
Current Liabilities:
Accounts payable	147,455	165,290
Accrued liabilities	308,148	424,336
Income taxes payable	17,947	39,191
Notes payable and current portion of long-term debt	417,065	298,963
Total Current Liabilities	890,615	927,780
Long-term debt	1,123,792	1,222,035
Deferred income taxes	218,624	232,641
Other noncurrent liabilities	353,556	340,398
Total Liabilities	2,586,587	2,722,854
Commitments and contingencies
Equity:
Preferred stock, $.01 par value; .25 million shares authorized; no shares issued	0	0
Common stock, $.01 par value; 200.0 million shares authorized; 162.8 million shares issued at June 30, 2013 and December 31, 2012	1,628	1,628
Capital in excess of par value	244,598	246,548
Retained earnings	2,959,391	2,818,461
Accumulated other comprehensive loss	(223,222)	(144,200)
Treasury stock, at cost,20.6 million and 20.5 million shares at June 30, 2013 and December 31, 2012, respectively	(732,210)	(713,739)
Total DENTSPLY International Equity	2,250,185	2,208,698
Noncontrolling Interests	37,911	40,745
Total Equity	2,288,096	2,249,443
Total Liabilities and Equity	$ 4,874,683	$ 4,972,297

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Jun. 30, 2013	Dec. 31, 2012
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	250,000.00	250,000.00
Preferred stock, shares issued	0	0
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	200,000,000.0	200,000,000.0
Common stock, shares issued	162,800,000	162,800,000
Treasury stock, shares	20,600,000	20,500,000

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Cash flows from operating activities:
Net income	$ 161,264	$ 136,269
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	41,743	40,357
Amortization	23,434	28,014
Amortization of deferred financing costs	2,592	2,391
Deferred income taxes	(8,564)	(4,432)
Share based compensation expense	12,023	11,029
Restructuring and other costs - non-cash	1,570	2,105
Stock option income tax benefit	(1,122)	(5,163)
Equity in earnings from unconsolidated affiliates	(403)	2,919
Other non-cash expense	11,480	(3,102)
Changes in operating assets and liabilities, net of acquisitions:
Accounts and notes receivable-trade, net	(72,324)	(41,461)
Inventories, net	(40,700)	(47,034)
Prepaid expenses and other current assets	26,364	(19,455)
Other noncurrent assets, net	845	(3,497)
Accounts payable	(11,143)	(1,320)
Accrued liabilities	(3,621)	(3,244)
Income taxes payable	(17,670)	5,423
Other noncurrent liabilities	6,100	3,596
Net cash provided by operating activities	131,868	103,395
Cash flows from investing activities:
Capital expenditures	(46,151)	(42,986)
Cash paid for acquisitions of businesses, net of cash acquired	(3,939)	0
Proceeds from Hedge, Investing Activities	7,499	0
Payments on settlement of net investment hedges	(94,843)	(14,221)
Expenditures for identifiable intangible assets	(963)	(188)
Purchase of Company-owned life insurance policies	0	(1,577)
Proceeds from sale of property, plant and equipment, net	2,209	465
Net cash used in investing activities	(136,188)	(58,507)
Cash flows from financing activities:
Net change in short-term borrowings	40,450	(35,181)
Cash paid for treasury stock	(62,278)	(38,840)
Cash dividends paid	(16,928)	(15,706)
Cash paid for contingent consideration on prior acquisitions	0	(1,781)
Cash paid for acquisition of noncontrolling interests of consolidated subsidiaries	(8,960)	0
Proceeds from exercise of stock options	31,213	20,066
Excess tax benefits from share based compensation	1,122	5,163
Interest Received on derivatives with an other than insignificant financing element	25	0
Payments for Hedge, Financing Activities	80	1,135
Net cash used in financing activities	(15,436)	(67,414)
Effect of exchange rate changes on cash and cash equivalents	(3,349)	(1,392)
Net (decrease) increase in cash and cash equivalents	(23,105)	(23,918)
Cash and cash equivalents at beginning of period	80,132	77,128
Cash and cash equivalents at end of period	$ 57,027	$ 53,210

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($) $ in Thousands	Total	Common Stock	Capital in Excess of Par Value	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Treasury Stock	Total DENTSPLY International Equity	Noncontrolling Interests
Beginning Balance at Dec. 31, 2011	$ 1,884,151	$ 1,628	$ 229,687	$ 2,535,709	$ (190,970)	$ (727,977)	$ 1,848,077	$ 36,074
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	136,269			134,049			134,049	2,220
Other Comprehensive Income (Loss), Net of Tax	(13,606)				(12,742)		(12,742)	(864)
Exercise of stock options	20,066		(7,158)			27,224	20,066
Tax benefit from stock options exercised	5,163		5,163				5,163
Share based compensation expense	11,029		11,029				11,029
Funding of Employee Stock Ownership Plan	3,642		370			3,272	3,642
Treasury shares purchased	(38,840)					(38,840)	(38,840)
RSU distributions	(3,276)		(8,344)			5,068	(3,276)
RSU dividends			115	(115)
Cash dividends ($0.125 in 2013, $0.110 in 2012 per share)	(15,599)			(15,599)			(15,599)
Ending Balance at Jun. 30, 2012	1,988,999	1,628	230,862	2,654,044	(203,712)	(731,253)	1,951,569	37,430
Beginning Balance at Dec. 31, 2012	2,249,443	1,628	246,548	2,818,461	(144,200)	(713,739)	2,208,698	40,745
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	161,264			158,913			158,913	2,351
Other Comprehensive Income (Loss), Net of Tax	(79,173)				(79,022)		(79,022)	(151)
Acquisition of noncontrolling interest	(8,960)		(3,926)				(3,926)	(5,034)
Exercise of stock options	31,213		(3,937)			35,150	31,213
Tax benefit from stock options exercised	1,122		1,122				1,122
Share based compensation expense	12,023		12,023				12,023
Funding of Employee Stock Ownership Plan	4,657		959			3,698	4,657
Treasury shares purchased	(62,278)					(62,278)	(62,278)
RSU distributions	(3,383)		(8,342)			4,959	(3,383)
RSU dividends			151	(151)
Cash dividends ($0.125 in 2013, $0.110 in 2012 per share)	(17,832)			(17,832)			(17,832)
Ending Balance at Jun. 30, 2013	$ 2,288,096	$ 1,628	$ 244,598	$ 2,959,391	$ (223,222)	$ (732,210)	$ 2,250,185	$ 37,911

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Parenthetical) - $ / shares	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Statement of Stockholders' Equity [Abstract]
Cash dividends, per share	$ 0.125	$ 0.11

SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
SIGNIFICANT ACCOUNTING POLICIES	Jun. 30, 2013
Notes to Financial Statements [Abstract]
SIGNIFICANT ACCOUNTING POLICIES	New Accounting Pronouncements In December 2011, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2011-11, “Balance Sheet (Topic 210): Disclosures about Offsetting Assets and Liabilities.” The standard requires entities to disclose both gross and net information about instruments and transactions that are offset in the Consolidated Balance Sheet, as well as instruments and transactions that are subject to an enforceable master netting agreement or similar agreement. In January 2013, The FASB issued ASU No. 2013-01, “Balance Sheet (Topic 210): Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities.” The standard clarifies the scope of the disclosure to apply only to derivatives, including bifurcated embedded derivatives, repurchase and reverse repurchase agreements as well as securities lending and borrowing transactions. The standard was effective January 1, 2013, with retrospective application required. The adoption of this standard did not have a material impact to the Company’s financial statements. The Company adopted this accounting standard during the quarter ended March 31, 2013. In July 2012, the FASB issued ASU No. 2012-02, “Intangibles - Goodwill and Other (Topic 350): Testing Indefinite-Lived Intangible Assets for Impairment.” This newly issued accounting standard is intended to reduce the cost and complexity of the annual indefinite-lived intangible asset impairment test by providing entities an option to perform a qualitative assessment to determine whether further impairment testing is necessary. Under the revised standard, an entity has the option to first assess qualitative factors to determine whether it is necessary to perform the current two-step impairment test. If an entity believes, as a result of its qualitative assessment, that it is more-likely-than-not that an indefinite-lived intangible asset is less than its carrying amount, the quantitative impairment test is required; otherwise, no further testing is required. Prior to the issuance of the revised standard, an entity was required to perform step one of the impairment test at least annually by calculating and comparing the fair value of an indefinite-lived intangible asset to its carrying amount. Under the revised standard, if an entity determines that step one is necessary and the indefinite-lived intangible asset is less than its carrying amount, then step two of the test will continue to be required to measure the amount of the impairment loss, if any. This ASU is effective for annual and interim indefinite-lived intangible asset impairment tests performed for fiscal years beginning after September 15, 2012. The adoption of this standard did not materially impact the Company’s financial position or results of operations. The Company adopted this accounting standard during the quarter ended March 31, 2013. In February 2013, the FASB issued ASU No. 2013-02, “Comprehensive Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income.” This newly issued accounting standard requires an entity to present, either on the face of the statement where net income is presented or in the notes, significant amounts reclassified out of AOCI by the respective line items of net income in its entirety in the same period. For other amounts not required to be reclassified to net income in the same reporting period, a cross reference to other disclosures that provide additional detail about the reclassification amounts is required. Since the standard only impacts the disclosure requirements of AOCI and does not impact the accounting for accumulated comprehensive income, the standard did not have an impact on the Company’s consolidated financial statements. The Company adopted this accounting standard during the quarter ended March 31, 2013.

STOCK COMPENSATION

6 Months Ended

Jun. 30, 2013

STOCK COMPENSATION [Abstract]

Stock Compensation

STOCK COMPENSATION

The following table represents total stock based compensation expense for non-qualified stock options, restricted stock units (“RSU”) and the tax related benefit for the three and six months ended June 30, 2013 and 2012:



	Three Months Ended				Six Months Ended
(in thousands)	2013		2012		2013		2012

Stock option expense	$	2,876	$	3,298	$	5,005	$	5,679
RSU expense	3,337		3,094		5,560		4,640
Total stock based compensation expense	$	6,213	$	6,392	$	10,565	$	10,319

Total related tax benefit	$	1,788	$	1,916	$	2,865	$	2,935

At June 30, 2013, the remaining unamortized compensation cost related to non-qualified stock options is $15.6 million, which will be expensed over the weighted average remaining vesting period of the options, or 1.7 years. At June 30, 2013, the unamortized compensation cost related to RSU is $26.3 million, which will be expensed over the remaining restricted period of the RSU, or 1.7 years.

The following table reflects the non-qualified stock option transactions from December 31, 2012 through June 30, 2013:



	Outstanding						Exercisable
(in thousands, except per share data)	Shares		Weighted Average Exercise Price		Aggregate Intrinsic Value		Shares	Weighted Average Exercise Price		Aggregate Intrinsic Value

Balance at December 31, 2012	9,906		$	33.18	$	69,079	7,599	$	31.79	$	64,819
Granted	911		40.91
Exercised	(1,110	)	28.11
Cancelled	(13	)	43.19
Forfeited	(116	)	38.76

Balance at June 30, 2013	9,578		$	34.43	$	66,655	7,400	$	33.05	$	62,541

At June 30, 2013, the weighted average remaining contractual term of all outstanding options is 5.9 years and the weighted average remaining contractual term of exercisable options is 5.0 years.

The following table summarizes the unvested RSU transactions from December 31, 2012 through June 30, 2013:



(in thousands, except per share data)	Shares		Weighted Average Grant Date Fair Value

Balance at December 31, 2012	1,034		$	36.34
Granted	499		40.89
Vested	(236	)	32.57
Forfeited	(120	)	38.75

Balance at June 30, 2013	1,177		$	38.78

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 40
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 14

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 123R
-Paragraph 64, 65, A240
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Statement of Position (SOP)
-Number 93-6
-Paragraph 53
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

COMPREHENSIVE INCOME

6 Months Ended

Jun. 30, 2013

COMPREHENSIVE INCOME [Abstract]

Comprehensive Income

COMPREHENSIVE INCOME

During the quarter ended June 30, 2013, foreign currency translation adjustments included currency translation gains of $1.3 million and gains on the Company’s loans designated as hedges of net investments of $4.0 million. During the quarter ended June 30, 2012, foreign currency translation adjustments included currency translation losses of $175.3 million and losses of $1.2 million on the Company’s loans designated as hedges of net investments. During the six months ended June 30, 2013, foreign currency translation adjustments included currency losses of $100.6 million and gains on the Company’s loans designated as hedges of net investments of $12.5 million. During the six months ended June 30, 2012, foreign currency translation adjustments included currency translation losses of $48.5 million and gains on the Company’s loans designated as hedges of net investments of $4.1 million. These foreign currency translation adjustments were offset by movements on derivative financial instruments, which are discussed in Note 10, Financial Instruments and Derivatives.

The cumulative foreign currency translation adjustments included translation gains of $77.1 million and $177.7 million at June 30, 2013 and December 31, 2012, respectively, were offset by losses of $110.9 million and $123.4 million, respectively, on loans designated as hedges of net investments. These foreign currency translation adjustments were partially offset by movements on derivatives financial instruments, which are discussed in Note 10, Financial Instruments and Derivatives.

Changes in AOCI, net of tax, by component for the six months ended June 30, 2013 and 2012:



(in thousands)	Foreign Currency Translation Adjustments			Gains and (Loss) on Derivative Financial Instruments			Net Unrealized Holding Gain on Available-for-Sale Securities			Pension Liability Adjustments			Total

Balance at December 31, 2012	$	54,302		$	(143,142	)	$	17,822		$	(73,182	)	$	(144,200	)

Other comprehensive (loss) income before reclassifications	(88,105		)	14,553			(8,989		)	1,439			(81,102		)

Amounts reclassified from accumulated other comprehensive income (loss)	—			203			—			1,877			2,080

Net (decrease) increase in other comprehensive income	(88,105		)	14,756			(8,989		)	3,316			(79,022		)

Balance at June 30, 2013	$	(33,803	)	$	(128,386	)	$	8,833		$	(69,866	)	$	(223,222	)



(in thousands)	Foreign Currency Translation Adjustments			Gains and (Loss) on Derivative Financial Instruments			Net Unrealized Holding (Loss) Gain on Available-for-Sale Securities			Pension Liability Adjustments			Total

Balance at December 31, 2011	$	(39,078	)	$	(117,390	)	$	(516	)	$	(33,986	)	$	(190,970	)

Other comprehensive (loss) income before reclassifications	(44,411		)	16,689			15,046			929			(11,747		)

Amounts reclassified from accumulated other comprehensive income (loss)	—			(1,732		)	—			737			(995		)

Net (decrease) increase in other comprehensive income	(44,411		)	14,957			15,046			1,666			(12,742		)

Balance at June 30, 2012	$	(83,489	)	$	(102,433	)	$	14,530		$	(32,320	)	$	(203,712	)

Reclassification out of accumulated other comprehensive income (expense) for the three and six months ended June 30, 2013 and 2012:



(in thousands)
Details about AOCI Components	Amounts Reclassified from AOCI						Affected Line Item in the Statements of Operations
	Three Months Ended June 30,
	2013			2012

Gains and loss on derivative financial instruments:
Interest rate swaps	$	(918	)	$	(897	)	Interest expense
Foreign exchange forward contracts	631			1,842			Cost of products sold
Foreign exchange forward contracts	(10		)	226			SG&A expenses
Commodity contracts	45			96			Cost of products sold
	(252		)	1,267			Net (loss) gain before tax
	171			(74		)	Tax benefit (expense)
	$	(81	)	$	1,193		Net of tax

Amortization of defined benefit pension and other postemployment benefit items:
Amortization of prior service benefits	$	33		$	33		(a)
Amortization of net actuarial losses	(1,357		)	(551		)	(a)
	(1,324		)	(518		)	Net loss before tax
	392			150			Tax benefit
	$	(932	)	$	(368	)	Net of tax

Total reclassifications for the period	$	(1,013	)	$	825

(a) These accumulated other comprehensive income components are included in the computation of net periodic benefit cost for the three months ended June 30, 2013 and 2012 (see Note 8, Benefit Plans, for additional details)



(in thousands)
Details about AOCI Components	Amounts Reclassified from AOCI						Affected Line Item in the Statements of Operations
	Six Months Ended June 30,
	2013			2012

Gains and loss on derivative financial instruments:
Interest rate swaps	$	(1,830	)	$	(1,802	)	Interest expense
Foreign exchange forward contracts	1,129			2,992			Cost of products sold
Foreign exchange forward contracts	(40		)	457			SG&A expenses
Commodity contracts	202			50			Cost of products sold
	(539		)	1,697			Net (loss) gain before tax
	336			35			Tax benefit (expense)
	$	(203	)	$	1,732		Net of tax

Amortization of defined benefit pension and other postemployment benefit items:
Amortization of prior service benefits	$	67		$	70		(b)
Amortization of net actuarial losses	(2,725		)	(1,107		)	(b)
	(2,658		)	(1,037		)	Net loss before tax
	781			300			Tax benefit
	$	(1,877	)	$	(737	)	Net of tax

Total reclassifications for the period	$	(2,080	)	$	995

(b) These accumulated other comprehensive income components are included in the computation of net periodic benefit cost for the six months ended June 30, 2013 and 2012 (see Note 8, Benefit Plans, for additional details)

- Definition

The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e689-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=20435746&loc=SL7669619-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 17
-URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e716-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e640-108580

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e709-108580

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e637-108580

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Reclassification Adjustments
-URI http://asc.fasb.org/extlink&oid=6522872

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e681-108580

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 130
-Paragraph 14-26
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

EARNINGS PER COMMON SHARE

6 Months Ended

Jun. 30, 2013

Notes to Financial Statements [Abstract]

EARNINGS PER COMMON SHARE

The dilutive effect of outstanding non-qualified stock options and RSU is reflected in diluted earnings per share by application of the treasury stock method. The following table sets forth the computation of basic and diluted earnings per common share for the three and six months ended June 30, 2013 and 2012:



Basic Earnings Per Common Share Computation	Three Months Ended				Six Months Ended
(in thousands, except per share amounts)	2013		2012		2013		2012

Net income attributable to DENTSPLY International	$	87,228	$	80,764	$	158,913	$	134,049

Weighted average common shares outstanding	142,922		141,737		142,849		141,729

Earnings per common share - basic	$	0.61	$	0.57	$	1.11	$	0.95

Diluted Earnings Per Common Share Computation
(in thousands, except per share amounts)

Net income attributable to DENTSPLY International	$	87,228	$	80,764	$	158,913	$	134,049

Weighted average common shares outstanding	142,922		141,737		142,849		141,729
Incremental weighted average shares from assumed exercise of dilutive options from stock-based compensation awards	2,211		2,126		2,258		2,179
Total weighted average diluted shares outstanding	145,133		143,863		145,107		143,908

Earnings per common share - diluted	$	0.60	$	0.56	$	1.10	$	0.93

Options to purchase 2.9 million and 3.5 million shares of common stock that were outstanding during the three and six months ended June 30, 2013, respectively, were not included in the computation of diluted earnings per common share since the options’ exercise price were greater than the average market price of the common shares and, therefore, the effect would be antidilutive. There were 3.8 million and 4.1 million antidilutive shares of common stock outstanding during the three and six months ended June 30, 2012, respectively.

BUSINESS ACQUISITIONS	6 Months Ended
BUSINESS ACQUISITIONS	Jun. 30, 2013
Notes to Financial Statements [Abstract]
BUSINESS ACQUISITIONS	BUSINESS ACQUISITIONS During the six months ended June 30, 2013, the Company paid $9.0 million to purchase the remaining outstanding shares of a consolidated subsidiary. As a result of the transaction, the Company recorded a decrease in noncontrolling interest of $5.0 million and a reduction to additional paid in capital of $3.9 million for the excess of the purchase price above the carrying value of the noncontrolling interest.

- Definition

The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1497-128463

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1490-128463

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1392-128463

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e7008-128479

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1486-128463

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e6927-128479

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4845-128472

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1500-128463

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1524-128463

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e7000-128479

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4922-128472

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4934-128472

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4926-128472

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e6996-128479

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1383-128463

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Emerging Issues Task Force (EITF)
-Number 88-16
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph F4
-Subparagraph e
-Appendix F

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 51, 52
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 67-73
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

SEGMENT AND GEOGRAPHIC INFORMATION

6 Months Ended

Jun. 30, 2013

Notes to Financial Statements [Abstract]

SEGMENT INFORMATION

The Company has numerous operating businesses covering a wide range of dental and certain healthcare products and geographic regions, primarily serving the professional dental market. Professional dental products represented approximately 88% and 89% of sales for the three months ended June 30, 2013 and 2012, respectively, and 89% of sales for both the six months ended June 30, 2013 and 2012.

The operating businesses are combined into operating groups, which have overlapping product offerings, geographical presence, customer bases, distribution channels, and regulatory oversight. These operating groups are considered the Company’s reportable segments as the Company’s chief operating decision-maker regularly reviews financial results at the operating group level and uses this information to manage the Company’s operations. The accounting policies of the segments are consistent with those described in the Company’s most recently filed Form 10-K in the summary of significant accounting policies. The Company measures segment income for reporting purposes as net operating income before restructuring and other costs, interest expense, interest income, other expense (income), net and provision for income taxes. Additionally, the operating segments are measured on net third party sales, excluding precious metal content. A description of the services provided within each of the Company’s four reportable segments is provided below.

During the first six months of 2013, the Company realigned certain implant and implant related businesses as a result of changes to the business structure. The segment information below reflects the revised structure for all periods shown.

Dental Consumable and Laboratory Businesses

This segment includes responsibility for the design, manufacturing, sales and distribution of certain small equipment and chairside consumable products in the United States, Germany and certain other European regions. It also has responsibility for the sales and distribution of certain Endodontic products in Germany. This segment also includes the responsibility for the design, manufacture, sales and distribution of most dental laboratory products, excluding certain countries. This segment is also responsible for most of the Company’s non-dental business excluding medical products.

Orthodontics/Canada/Mexico/Japan

This segment is responsible for the worldwide manufacturing, sales and distribution of the Company’s Orthodontic products. It also has responsibility for the sales and distribution of most of the Company’s dental products sold in Japan, Canada and Mexico.

Select Distribution Businesses

This segment includes responsibility for the sales and distribution for most of the Company’s dental products sold in France, United Kingdom, Italy, Austria and certain other European countries, Middle Eastern countries, India and Africa. Operating margins of the segment are reflective of the intercompany transfer price of products manufactured by other operating segments.

Implants/Endodontics/Healthcare/Pacific Rim

This segment includes the responsibility for the design, manufacture, sales and distribution of most of the Company’s dental implant and related products. This segment also includes the responsibility for the design and manufacturing of Endodontic products and is responsible for the sales and distribution of the Company’s Endodontic products in the United States, Switzerland, and locations not covered by other selling divisions. In addition, this segment is also responsible for sales and distribution of certain Endodontic products in Germany, Asia and other parts of the world. Additionally, this segment is responsible for the design and manufacture of certain dental consumables and dental laboratory products and the sales and distribution of most dental products sold in Brazil, Latin America (excluding Mexico), Australia and most of Asia (excluding India and Japan). This segment is also responsible for the worldwide design, manufacturing, sales and distribution of the Company’s healthcare products (non-dental) throughout most of the world.

Significant interdependencies exist among the Company’s operations in certain geographic areas. Inter-group sales are at prices intended to provide a reasonable profit to the manufacturing unit after recovery of all manufacturing costs and to provide a reasonable profit for purchasing locations after coverage of marketing and general and administrative costs.

Generally, the Company evaluates performance of the segments based on the groups’ operating income, excluding restructuring and other costs, and net third party sales, excluding precious metal content.

The following tables set forth information about the Company’s segments for the three and six months ended June 30, 2013 and 2012:

Third Party Net Sales



	Three Months Ended						Six Months Ended
(in thousands)	2013			2012			2013			2012

Dental Consumable and Laboratory Businesses	$	255,223		$	266,244		$	519,852		$	521,379
Orthodontics/Canada/Mexico/Japan	82,079			83,195			153,414			153,549
Select Distribution Businesses	66,115			63,753			126,929			122,846
Implants/Endodontics/Healthcare/Pacific Rim	358,453			352,657			695,097			685,802
All Other (a)	(860		)	(2,855		)	(2,198		)	(4,169		)
Total	$	761,010		$	762,994		$	1,493,094		$	1,479,407

(a) Includes amounts recorded at Corporate headquarters.

Third Party Net Sales, Excluding Precious Metal Content



	Three Months Ended						Six Months Ended
(in thousands)	2013			2012			2013			2012

Dental Consumable and Laboratory Businesses	$	218,794		$	211,604		$	430,824		$	423,713
Orthodontics/Canada/Mexico/Japan	73,900			73,915			138,871			137,208
Select Distribution Businesses	65,981			63,592			126,698			122,524
Implants/Endodontics/Healthcare/Pacific Rim	358,140			352,224			694,410			684,830
All Other (b)	(860		)	(2,855		)	(2,198		)	(4,169		)
Total excluding precious metal content	715,955			698,480			1,388,605			1,364,106
Precious metal content	45,055			64,514			104,489			115,301
Total including precious metal content	$	761,010		$	762,994		$	1,493,094		$	1,479,407

(b) Includes amounts recorded at Corporate headquarters.

Inter-segment Net Sales



	Three Months Ended						Six Months Ended
(in thousands)	2013			2012			2013			2012

Dental Consumable and Laboratory Businesses	$	54,907		$	56,852		$	106,739		$	109,321
Orthodontics/Canada/Mexico/Japan	937			1,054			1,766			2,233
Select Distribution Businesses	213			401			1,504			795
Implants/Endodontics/Healthcare/Pacific Rim	32,387			38,186			66,411			72,225
All Other (c)	60,238			56,328			117,665			110,309
Eliminations	(148,682		)	(152,821		)	(294,085		)	(294,883		)
Total	$	—		$	—		$	—		$	—

Segment Operating Income (Loss)



	Three Months Ended						Six Months Ended
(in thousands)	2013			2012			2013			2012

Dental Consumable and Laboratory Businesses	$	65,589		$	65,251		$	127,339		$	128,596
Orthodontics/Canada/Mexico/Japan	5,028			3,228			6,891			2,961
Select Distribution Businesses	(671		)	(1,020		)	(2,296		)	(2,461		)
Implants/Endodontics/Healthcare/Pacific Rim	78,503			77,095			142,354			142,478
All Other (d)	(23,414		)	(33,119		)	(54,730		)	(71,743		)
Segment operating income	125,035			111,435			219,558			199,831

Reconciling Items:
Restructuring and other costs	2,169			2,528			2,834			3,765
Interest expense	11,507			14,323			26,728			30,105
Interest income	(2,243		)	(1,984		)	(4,418		)	(3,862		)
Other expense (income), net	4,223			982			7,141			1,045
Income before income taxes	$	109,379		$	95,586		$	187,273		$	168,778

(d) Includes the results of Corporate headquarters, inter-segment eliminations and one distribution warehouse not managed by named segments.



Assets
(in thousands)	June 30, 2013		December 31, 2012

Dental Consumable and Laboratory Businesses	$	973,168	$	1,007,307
Orthodontics/Canada/Mexico/Japan	299,275		294,348
Select Distribution Businesses	170,824		192,684
Implants/Endodontics/Healthcare/Pacific Rim	3,157,931		3,195,382
All Other (e)	273,485		282,576
Total	$	4,874,683	$	4,972,297

(e) Includes the assets of Corporate headquarters, inter-segment eliminations and one distribution warehouse not managed by named segments.

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 131
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

INVENTORIES

6 Months Ended

Jun. 30, 2013

Notes to Financial Statements [Abstract]

INVENTORIES

Inventories are stated at the lower of cost or market. At June 30, 2013 and December 31, 2012, the cost of $7.2 million and $6.3 million, respectively, was determined by the last-in, first-out (“LIFO”) method. The cost of other inventories was determined by the first-in, first-out (“FIFO”) or average cost methods. If the FIFO method had been used to determine the cost of LIFO inventories, the amounts at which net inventories are stated would be higher than reported at June 30, 2013 and December 31, 2012 by $6.0 million and $5.9 million, respectively.

The Company establishes reserves for inventory estimated to be obsolete or unmarketable. Assumptions about future demand and market conditions are considered when estimating these reserves. The inventory valuation reserves were $33.9 million and $32.6 million at June 30, 2013 and December 31, 2012, respectively.

Inventories, net of inventory valuation reserves, consist of the following:



(in thousands)	June 30, 2013		December 31, 2012

Finished goods	$	263,590	$	248,870
Work-in-process	76,019		72,533
Raw materials and supplies	93,580		81,537
	$	433,189	$	402,940

BENEFIT PLANS

6 Months Ended

Jun. 30, 2013

Notes to Financial Statements [Abstract]

BENEFIT PLANS

The following sets forth the components of net periodic benefit cost of the Company’s defined benefit plans and for the Company’s other postemployment benefit plans for the three and six months ended June 30, 2013 and 2012:



Defined Benefit Plans	Three Months Ended						Six Months Ended
(in thousands)	2013			2012			2013			2012

Service cost	$	3,662		$	3,032		$	7,385		$	6,010
Interest cost	2,445			2,627			4,922			5,318
Expected return on plan assets	(1,230		)	(1,189		)	(2,477		)	(2,414		)
Amortization of prior service benefit	(33		)	(33		)	(67		)	(70		)
Amortization of net actuarial loss	1,269			494			2,549			992
Curtailments and settlement gains	(235		)	—			(625		)	—

Net periodic benefit cost	$	5,878		$	4,931		$	11,687		$	9,836



Other Postemployment Benefit Plans	Three Months Ended				Six Months Ended
(in thousands)	2013		2012		2013		2012

Service cost	$	61	$	18	$	123	$	37
Interest cost	122